When you start taking a weight loss medication prescribed by your doctor, you expect it to help you lose weight safely without causing serious harm. Unfortunately, popular weight loss drugs like Ozempic, Wegovy, and Mounjaro have been linked to severe gastrointestinal injuries, vision loss, and other life-threatening complications. With thousands of lawsuits filed nationwide against manufacturers such as Novo Nordisk and Eli Lilly, many New York residents are now seeking compensation for serious injuries caused by these medications. If you or a loved one has suffered serious injuries from weight loss drugs, the experienced attorneys at the Porter Law Group are here to help fight for the compensation you deserve.
Settlement
Jury Verdict
Settlement
Settlement
Weight loss drug injury cases involve complex medical evidence and require specialized knowledge of pharmaceutical litigation to successfully challenge major drug manufacturers. Our skilled legal team at The Porter Law Group has the expertise necessary to handle these emerging cases across New York State. We thoroughly investigate gastroparesis, intestinal blockages, vision loss, and other serious complications while building compelling cases against pharmaceutical giants who failed to adequately warn patients about dangerous side effects.
We offer free, no-obligation consultations and work on a contingency fee basis—meaning you pay no fees unless we win your case. Our attorneys understand the complexities of the federal multidistrict litigation system and coordinate with leading national counsel to ensure New York residents receive maximum compensation. Contact us today at 833-PORTER9 or email info@porterlawteam.com to learn how we can help hold drug manufacturers accountable for your injuries.
Weight loss drug injury lawsuits have emerged as one of the most significant areas of pharmaceutical litigation. New York residents are pursuing compensation through both the federal MDL system and individual state court actions.
As of May 2025, more than 1,800 lawsuits have been consolidated in federal multidistrict litigation (MDL 3094), primarily involving GLP-1 receptor agonists. These medications have been linked to gastroparesis (stomach paralysis), intestinal blockages, and vision loss.
Under New York’s product liability laws, you do not need to prove negligence. You only need to show that the medication was defective due to inadequate warnings and that the defect caused your injury. This is especially relevant when manufacturers may have known of serious side effects but failed to inform patients or doctors.
New York also regulates weight loss product safety, including banning the sale of over-the-counter diet pills for minors. These laws may provide additional legal avenues for compensation under state consumer protection rules.
Current litigation encompasses a wide range of medications prescribed for both diabetes management and weight loss, manufactured by major pharmaceutical companies:
Novo Nordisk Products:
Eli Lilly Products:
Other Manufacturers:
Weight loss drug injuries encompass a range of serious medical conditions that can result in substantial compensation for victims and their families.
Gastroparesis (Stomach Paralysis): This represents the most frequently alleged injury in weight loss drug lawsuits, affecting the stomach's ability to empty properly. Gastroparesis can cause severe nausea, persistent vomiting, abdominal bloating and pain, malnutrition and dangerous weight loss, and dehydration requiring hospitalization. The condition may persist even after discontinuing the medication, leading to long-term complications requiring ongoing medical treatment, dietary modifications, and potentially surgical intervention.
Gastrointestinal Obstructions: Lawsuits frequently involve claims of ileus (intestinal paralysis) and bowel obstructions that can be life-threatening without immediate medical intervention. These conditions often require emergency surgery to remove blockages, can cause severe abdominal pain and inability to eat, may result in permanent damage to intestinal function, and can lead to sepsis or other life-threatening complications if not treated promptly.
Vision Loss (NAION): Recent Harvard Medical School research has linked GLP-1 medications to non-arteritic anterior ischemic optic neuropathy (NAION), a condition causing sudden, permanent vision loss. Diabetic patients using semaglutide were found to be nearly five times more likely to develop this rare but devastating eye condition. Vision loss can be partial or complete, typically affects one eye initially but may progress to both eyes, and is generally irreversible despite treatment attempts.
Additional Serious Complications: Other reported injuries include pancreatitis and potential pancreatic cancer risk, gallbladder disease requiring surgical removal, blood clots including deep vein thrombosis and pulmonary embolism, and severe dehydration and electrolyte imbalances. These complications can require extensive medical treatment, multiple hospitalizations, and result in permanent health problems affecting quality of life and earning capacity.
While the weight loss drug litigation is still developing with no major settlements reached as of 2025, legal experts have provided projected compensation ranges based on similar pharmaceutical litigation patterns.
Projected Settlement Ranges:
Federal MDL Progress: The federal multidistrict litigation (MDL 3094) has grown to over 1,800 active cases as of May 2025, with new plaintiffs joining monthly. The MDL court held a critical Rule 702 hearing in May 2025 regarding the admissibility of expert causation testimony, which will determine which cases can proceed to trial. Defense attorneys are challenging expert opinions that lack gastric emptying tests to confirm gastroparesis diagnoses, highlighting the importance of proper medical documentation.
Timeline for Resolution: Legal experts predict the litigation will take several years to resolve, with the first bellwether trials expected in 2026 or 2027. Key milestones include completion of fact discovery in late 2025, expert discovery and Daubert hearings in 2026, bellwether trials in 2026-2027, and potential global settlement negotiations in 2027-2028. Based on similar pharmaceutical litigation patterns, any eventual settlements could reach billions of dollars given the number of cases and severity of injuries involved.
Weight loss drug injury cases often involve multiple parties in the pharmaceutical development, manufacturing, and distribution process, creating opportunities for comprehensive compensation.
Pharmaceutical Manufacturers: Companies like Novo Nordisk and Eli Lilly bear primary responsibility for conducting adequate safety testing, providing proper warnings about serious risks, monitoring post-market safety data, and updating labeling when new risks are identified. Manufacturers can be liable for design defects making medications unreasonably dangerous, failure to warn about known serious side effects, and inadequate post-market surveillance and reporting.
Healthcare Providers: While less common, healthcare providers may face liability for prescribing medications inappropriately, failing to monitor patients for known side effects, continuing prescriptions despite warning signs, or failing to obtain proper informed consent. These cases typically involve additional medical malpractice claims separate from product liability actions against manufacturers.
Pharmacies and Distributors: In some cases, pharmacies may face liability for dispensing medications without proper patient counseling, failing to identify dangerous drug interactions, or continuing to dispense recalled or contraindicated medications. However, most weight loss drug cases focus primarily on manufacturer liability for inadequate warnings and safety testing.
Weight loss drug injuries can result in substantial compensation covering both economic losses and the significant pain and suffering these conditions cause.
Medical Expenses: Weight loss drug injuries frequently require extensive medical care due to the chronic nature of conditions like gastroparesis and the need for ongoing monitoring and treatment. Compensation covers emergency room visits and hospitalizations, diagnostic testing including gastric emptying studies, specialist consultations with gastroenterologists and other experts, surgical procedures for intestinal blockages, long-term medications and medical equipment, nutritional support and dietary counseling, and ongoing monitoring for complications. Severe cases may require hundreds of thousands of dollars in medical treatment over many years.
Lost Income and Earning Capacity: Chronic gastrointestinal conditions can significantly impact victims' ability to work and maintain their careers. Compensation includes lost wages during treatment and recovery, reduced earning capacity due to ongoing symptoms, inability to perform job functions requiring physical stamina, medical leave and reduced work schedules, and potential need for career changes due to health limitations. Young victims who develop chronic conditions may face decades of reduced earning potential.
Pain and Suffering: Weight loss drug injuries often cause severe physical pain and emotional distress that significantly impacts quality of life. Gastroparesis victims may experience constant nausea, inability to eat normal meals, social isolation due to symptoms, anxiety about eating and digestive function, and depression related to chronic illness. Vision loss victims face the traumatic experience of sudden blindness, need for lifestyle adaptations, and psychological impact of permanent disability. New York allows substantial compensation for these non-economic damages based on the severity and permanence of injuries.
Future Medical Needs: Many weight loss drug injuries require lifelong medical management, making future medical expenses a significant component of compensation. This includes ongoing specialist care, prescription medications, medical devices and equipment, potential surgical interventions, and regular monitoring for complications or disease progression.
New York imposes strict deadlines for filing weight loss drug injury lawsuits that must be carefully observed to preserve your legal rights.
General Statute of Limitations: Most weight loss drug injury cases must be filed within three years from either the date of injury or discovery of the connection between the medication and the injury. For immediate injuries like severe gastroparesis symptoms, the timeline typically begins when symptoms first appeared. For delayed-onset conditions or cases where the connection to the medication wasn't immediately apparent, the discovery rule may apply to extend the deadline.
Product Liability Claims: Defective product cases, including weight loss drug failures to warn, generally must be filed within three years of injury or discovery of the defect. Courts will examine when a reasonable person would have discovered that their injury was caused by the medication, which may be later than the initial symptom onset.
Special Considerations: For individuals under 18 when injured, the statute of limitations typically doesn't begin until they reach adulthood. Cases involving death must be filed within two years of the date of death. Claims against government entities or healthcare providers may have different, often shorter deadlines.
The complexity of determining when the statute of limitations begins in weight loss drug cases makes early consultation with experienced attorneys essential for protecting your rights and ensuring timely filing of necessary legal documents.
The federal MDL 3094 has become the primary vehicle for weight loss drug injury claims, offering advantages for coordinated discovery and expert development.
MDL Structure and Benefits: The MDL includes cases against multiple manufacturers including Novo Nordisk, Eli Lilly, and others, allowing for coordinated discovery and shared resources in developing evidence. Plaintiffs benefit from economies of scale in expert witness development, coordinated fact discovery from manufacturers, and shared litigation costs among participating attorneys. The MDL also provides faster resolution than individual cases filed separately.
Qualifying Injuries: To participate in the MDL, cases must involve gastroparesis or stomach paralysis requiring medical treatment, gastrointestinal obstruction or ileus requiring hospitalization, intestinal blockages necessitating surgical intervention, or NAION or vision loss related to medication use. Other injuries may be pursued in individual state court actions.
Recent Developments: The MDL court's May 2025 Rule 702 hearing addressed critical causation issues that will determine which cases can proceed to trial. Defense challenges to expert testimony lacking gastric emptying tests emphasize the importance of proper diagnostic documentation. The court's decisions on expert admissibility will significantly impact case values and settlement negotiations.
Weight loss drug manufacturers have vast resources and employ teams of experienced attorneys and medical experts specifically to defend against injury claims. Without skilled legal representation, victims may not receive fair compensation or may have valid claims dismissed due to the complex medical and legal issues involved.
Pharmaceutical companies often argue that injuries resulted from underlying medical conditions, other medications, or factors unrelated to their weight loss drugs. They may claim that their FDA-approved labeling was adequate or that patients were properly warned about potential risks. Overcoming these defenses requires attorneys who understand both pharmaceutical litigation and the evolving medical understanding of GLP-1 medication side effects.
Our team at the Porter Law Group handles all aspects of complex pharmaceutical litigation including coordination with MDL counsel, medical evidence development, expert witness preparation, and aggressive advocacy against well-funded corporate defense teams. We're prepared to take on major pharmaceutical companies to secure fair compensation and hold them accountable for inadequate warnings about serious medication risks.
Q: How do I know if my symptoms were caused by weight loss medication?
Weight loss drug injuries often follow specific patterns like gastroparesis symptoms developing during or after medication use, digestive problems that persist after stopping the medication, or vision loss occurring while taking GLP-1 drugs. Our attorneys work with medical experts to investigate the connection between your medication use and subsequent health problems.
Q: Can I file a lawsuit if my doctor prescribed the medication off-label?
Yes. Off-label prescribing doesn't prevent product liability claims against manufacturers. Even if your doctor prescribed a diabetes medication for weight loss, you may still have a valid claim if the manufacturer failed to provide adequate warnings about serious risks.
Q: What if I'm still taking the weight loss medication?
You should consult with your doctor about whether to continue the medication while also consulting with an attorney about your legal rights. Don't stop taking prescribed medications without medical supervision, but document any symptoms you're experiencing.
Q: How long do weight loss drug injury cases take to resolve?
Most cases are expected to take several years due to the complexity of the litigation and the MDL process. Bellwether trials are expected in 2026-2027, with potential global settlements following. However, individual cases with strong evidence and severe injuries may resolve sooner.
Q: What if I don't have gastric emptying test results?
While gastric emptying studies provide strong evidence of gastroparesis, other medical evidence may support your case. Our attorneys work with medical experts to evaluate all available evidence and determine the strength of your claim.
Q: Can I participate in both the MDL and file an individual lawsuit?
Cases are typically either part of the MDL or filed individually, not both. Our attorneys will evaluate your case to determine the best legal strategy and forum for pursuing maximum compensation.
Q: What if the manufacturer claims FDA approval protects them?
FDA approval doesn't shield manufacturers from liability for failure to warn about risks they knew or should have known about. Many successful pharmaceutical cases involve FDA-approved drugs where manufacturers had additional safety information not reflected in approved labeling.
Are You Suffering Stomach Problems Because Of A Weight Loss Drug?
Reach out to our experienced team for a free consultation.
The lawyers at the Porter Law Group have decades of experience representing individuals and families whose lives have been devastated by catastrophic injuries. We have obtained some of the largest settlements and verdicts in courts throughout the State of New York. We are a state-wide firm that handles cases with a hometown feel.
Our clients come to us looking for guidance and answers about complex pharmaceutical litigation involving cutting-edge medications and evolving medical science. With seasoned trial lawyers, the Porter Law Group has the resources necessary to help you navigate the most complex weight loss drug injury cases against major pharmaceutical corporations that will stop at nothing to prevent you from receiving the compensation you deserve.
You only get one chance to hire the best lawyer for you and your family. Hire the lawyers most recommended by former clients and local attorneys, and the firm that obtains superior results.
When you or a loved one's life has been devastated by a serious weight loss drug injury in New York, don't hire a lawyer without calling the Porter Law Group to learn why so many of our clients are thankful they trusted us with their case in their time of need.
At the Porter Law Group, we understand the immense physical, emotional, and financial toll that weight loss drug injuries can take on you and your family. Let us handle the complex medical and legal issues involved in pharmaceutical litigation while you focus on your recovery and health management.
Don't let pharmaceutical companies minimize your injuries with inadequate compensation offers. Weight loss drug injury cases require immediate action due to strict statute of limitations deadlines, and the federal MDL system provides unique opportunities for coordinated discovery and expert development that may not be available if you wait too long. Time is critical for preserving crucial medical evidence and ensuring your case is properly documented before memories fade and records are lost.
Take advantage of a free case evaluation with our experienced New York weight loss drug injury lawyers by calling 833-PORTER9 or emailing info@porterlawteam.com. We proudly serve clients throughout New York State and are ready to help you pursue the justice you deserve against major pharmaceutical corporations.
*Prior results do not guarantee a similar outcome.
Post Image: Photo by Christine Sandu on Unsplash
Avoid sharing confidential information via contact form, text, or voicemail as they are not secure. Please be aware that using any of these communication methods does not establish an attorney-client relationship. *By appointment only.
The information contained on this site is proprietary and protected. Any unauthorized or illegal use, copying, or dissemination will be prosecuted to the fullest extent of the law. All content on this site is provided for informational purposes only. It is not, nor should it be taken as medical or legal advice. None of the content on this site is intended to substitute for medical advice, diagnosis, or treatment. Attorney Advertising.
We serve clients in every city and county in New York State. These include places like: The Adirondacks, Albany, Alexandria Bay, Amsterdam, Astoria, Auburn, Ballston Spa, Batavia, Beacon, Binghamton, Brooklyn, Buffalo, Canandaigua, Carthage, Cattaraugus, Catskill, Cayuga Lake, Cazenovia, Chelsea, Clayton, Clifton Park, Cobleskill, Colonie, Cooperstown, Corning, Cortland, Delhi, Delmar, Dunkirk, East Aurora, East Hampton, Elmira, Fayetteville, Finger Lakes, Flushing, Fredonia, Fulton, Garden City, Geneva, Glen Cove, Glens Falls, Gloversville, Gouverneur, Great Neck, Greenwich Village, Hamilton, Hammondsport, Harlem, Haverstraw, Hempstead, Herkimer, Hornell, Hudson, Huntington, Ilion, Ithaca, Jamaica, Jamestown, Johnstown, Kingston, Lake George, Lake Placid, Lewiston, Little Falls, Liverpool, Lockport, Long Island City, Lowville, Malone, Manhattan, Manlius, Massena, Medina, Middletown, Monticello, Montauk, Mount Vernon, New Paltz, New Rochelle, Newburgh, Niagara Falls, North Tonawanda, Norwich, Nyack, Ogdensburg, Old Forge, Olean, Oneida, Oneonta, Ossining, Oswego, Penn Yan, Peekskill, Plattsburgh, Port Chester, Potsdam, Poughkeepsie, Queens, Rhinebeck, Riverhead, Rochester, Rome, Rye, Sag Harbor, Saranac Lake, Saratoga Springs, Schenectady, Seneca Falls, Seneca Lake, Skaneateles, SoHo, Southampton, Spring Valley, Staten Island, Stony Brook, Suffern, Syracuse, Tarrytown, The Bronx, Thousand Islands, Ticonderoga, Troy, Tupper Lake, Utica, Warsaw, Waterloo, Watertown, Watkins Glen, Wellsville, White Plains, Williamsburg, Woodstock, Yonkers, and many more communities throughout New York State.
Copyright © 2025, Porter Law Group. Personal Injury Lawyers
Made with 💛 by Gold Penguin
